| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583951 | Seminars in Arthritis and Rheumatism | 2017 | 21 Pages |
Abstract
The co-occurrence of RA with ESRD was 1.1% in the USRDS by 2011. Physicians should be aware of the critical impact of the comorbidities of diabetes and hypertension in causing ESRD in RA patients. Use of DMARDS other than hydroxychloroquine and biologics to treat RA in the setting of ESRD appears to be infrequent. Further prospective studies of treatment strategies for RA in ESRD are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Sunita MD, Frances M. PhD, Christopher BS, Chen-Chun MPH, Michael BS, Monique MD, Shilpa MD, Norris Stanley MD, Laura MD,